TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/24 20:29 | 9/13/24 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gaugler Daryl | FL | O | COO | S | -6 | 12.86 | 0 | -1 | 0 | 116 | D | ||||||||||||||
6/13/24 18:13 | 6/13/24 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gaugler Daryl | FL | O | COO | S | -28 | 28.38 | 0 | -1 | -1 | 116 | D | ||||||||||||||
6/7/23 21:22 | 6/5/23 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gaugler Daryl | FL | O | COO | S.m | -118 | 38.52 | 0 | -3 | -12 | 22 | D | ||||||||||||||
6/2/23 18:28 | 5/31/23 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gaugler Daryl | FL | O | COO | S.d | -98 | 39.08 | 0 | -3 | -9 | 25 | D | ||||||||||||||
6/8/22 19:24 | 6/6/22 | PCRX | Pacira Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gaugler Daryl | FL | O | COO | S.d | -68 | 61.37 | 0 | -1 | -4 | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |